Dais Partners with China-Based Global Consulting Firm to Establish Subsidiary in China

Nanotech Investing

Dais Analytic (OTCQB:DLYT) has announced it has partnered with Umore Consulting to help establish a Dais subsidiary in the People’s Republic of China. As quoted in the press release: The Company signaled, with the signing of this agreement, the need to have an in-country subsidiary to grow its business interests in China. The expansion is …

Dais Analytic (OTCQB:DLYT) has announced it has partnered with Umore Consulting to help establish a Dais subsidiary in the People’s Republic of China.

As quoted in the press release:

The Company signaled, with the signing of this agreement, the need to have an in-country subsidiary to grow its business interests in China. The expansion is projected to come from a more concentrated focus to increase the sales (and servicing) of Aqualyte™ nanomaterial, NanoClear™ industrial waste water treatment systems, and ConsERV™ components or systems for heating, ventilating, and air-conditioning (HVAC) energy and CO2 savings.
It is anticipated over time this subsidiary will serve as a base for sales in the broader Southeast Asian market. It is Dais’s plan to have this subsidiary provide key functions such as in-country management, marketing, business development and sales support, technical support, and manufacturing focused on a more rapid and efficient expansion of Dais’s business in China which it has identified as a strategic growth market.
“The strategic partnership between Dais Analytic and Umore brings the strengths of our two companies together addressing the growing market opportunities for Dais’s nanomaterial technology in the clean air, energy, and water industries. The key deliverable of our partnering is funding and a functional in-country business entity tasked solely to grow revenue, partnerships, and manufacturing in the local China markets,” said Rong Xu, CEO of Umore Consulting.
“We are pleased to announce Dais is partnering with Umore, a capable and well-known firm in the cleantech industry. We believe our efforts and skills will combine to create this Dais subsidiary in China, and to extend our successes to date in partnering, licensing and selling product into multiple sales channels in the important China market. It is the next logical step to more rapidly accelerate revenues from the sale of our innovative, state-of-the-art, proprietary products. This announcement solidifies our commitment to China,” says Tim Tangredi, Dais’s CEO.

Click here to read the full press release.

Nanotech Investing